ArticleCancer research2008

WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth.

Liangyou Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.